According to CCTV reports, Abdi Mahmoud, WHO’s COVID-19 response officer, said in Geneva, Switzerland on the 4th,More and more studies have shown that Omi Kiron strain mainly affects the upper respiratory tract, and its symptoms are milder than those caused by other strains of pneumonia.
access:
ECS year-end special: cloud server as low as 38 yuan/year
He said that this may be good news, but more research is needed to confirm it. At the same time, Omi Keron’s high infectiousness means that it will become a mainstream strain in some places within a few weeks. It poses a threat to countries and regions with a relatively high proportion of people who have not received the new crown vaccine.
Abdi Mahmoud stated that research shows thatThe new crown vaccines such as Sinopharm and Kexing can prevent the risk of severe hospitalization caused by the Omi Keron strain. It is expected that the protection of the vaccine for severely hospitalized patients will continue to be maintained.
Abdi Mahmoud also pointed out that despite the rapid decline in the number of new cases in South Africa after the surge, and the hospitalization rate and mortality rate are low, high-risk groups and unvaccinated people may still be infected with the Omi Keron strain. And developed into a severely ill patient.
The latest WHO data shows that Omi Keron has appeared in at least 128 countries and regions.
.